BIO Letter to Angela Merkel on the Benefits of Biotech
July 15, 2021
As you prepare for Chancellor Merkel’s visit to Washington, we, the representatives of America’s biotechnology sector thought that you and your government might benefit from an update on all that our sector is doing globally to address the ongoing COVID crisis, and in particular to ensure that patients in low-and middle-income countries get quick, safe access to COVID vaccines. The Biotechnology Innovation Organization (BIO) is the world’s largest biotechnology organization, with about 1000 members of all sizes, but most of whom are small and medium sized companies. BIO also has an extensive network of relationships with biotechnology associations around the world, including those in Germany.
BIO submits comments on the MDH’s proposed regulations regarding Drugs of Substantial Public Interest: Draft Methodology for Public Comment as required in statute by the Prescription Drug Price Transparency Act.
The Biotechnology Innovation Organization appreciates the opportunity to comment on the Center for Medicare and Medicaid Services’ Information Collection Request on the Part C and Part D Medicare Prescription Payment Plan Model Documents.
As you prepare for Chancellor Merkel’s visit to Washington, we, the representatives of America’s biotechnology sector thought that you and your government might benefit from an update on all that our sector is doing globally to address the ongoing COVID crisis, and in particular to ensure that patients in low-and middle-income countries get quick, safe access to COVID vaccines. The Biotechnology Innovation Organization (BIO) is the world’s largest biotechnology organization, with about 1000 members of all sizes, but most of whom are small and medium sized companies. BIO also has an extensive network of relationships with biotechnology associations around the world, including those in Germany.